(Q40595026)

English

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report

scientific article published on November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report (English)

1 reference

Europe PubMed Central

21 September 2017

phase I clinical trial

0 references

0 references

phase II clinical trial

0 references

author name string

Teh BS

1

1 reference

Europe PubMed Central

21 September 2017

Aguilar-Cordova E

2

1 reference

Europe PubMed Central

21 September 2017

Kernen K

3

1 reference

Europe PubMed Central

21 September 2017

Chou CC

4

1 reference

Europe PubMed Central

21 September 2017

Shalev M

5

1 reference

Europe PubMed Central

21 September 2017

Vlachaki MT

6

1 reference

Europe PubMed Central

21 September 2017

Miles B

7

1 reference

Europe PubMed Central

21 September 2017

Kadmon D

8

1 reference

Europe PubMed Central

21 September 2017

Mai WY

9

1 reference

Europe PubMed Central

21 September 2017

Caillouet J

10

1 reference

Europe PubMed Central

21 September 2017

Davis M

11

1 reference

Europe PubMed Central

21 September 2017

Ayala G

12

1 reference

Europe PubMed Central

21 September 2017

Wheeler T

13

1 reference

Europe PubMed Central

21 September 2017

Brady J

14

1 reference

Europe PubMed Central

21 September 2017

Carpenter LS

15

1 reference

Europe PubMed Central

21 September 2017

Lu HH

16

1 reference

Europe PubMed Central

21 September 2017

Chiu JK

17

1 reference

Europe PubMed Central

21 September 2017

Woo SY

18

1 reference

Europe PubMed Central

21 September 2017

Thompson T

19

1 reference

Europe PubMed Central

21 September 2017

Butler EB

20

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 November 2001

1 reference

Europe PubMed Central

21 September 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

21 September 2017

51

1 reference

Europe PubMed Central

21 September 2017

605-613

1 reference

Europe PubMed Central

21 September 2017

3

1 reference

Europe PubMed Central

21 September 2017

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy or prostatectomy: an old conflict revisited in the PSA era. A radiation oncologist's viewpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-dimensional conformal radiotherapy and dose escalation: where do we stand?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression in untreated carcinoma of the prostate metastatic to regional lymph nodes (stage t0 to 4,N1 to 3.M0,D1). European Organization for Research and Treatment of Cancer Genitourinary Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year outcomes for pathologic node-positive patients treated in RTOG 75-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prodrug activation gene therapy and external beam irradiation in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ionizing radiation greatly improves gene transfer efficiency in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained enhancement of liposome-mediated gene delivery and gene expression in human breast tumour cells by ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The future of gene therapy in the treatment of urologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytopathic effect of in situ gene therapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901692-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(01)01692-3

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40595026&oldid=1903495412"